Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis
- PMID: 10228018
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis
Abstract
CD4 T cells are important in the protective immune response against tuberculosis. Two mouse models deficient in CD4 T cells were used to examine the mechanism by which these cells participate in protection against Mycobacterium tuberculosis challenge. Transgenic mice deficient in either MHC class II or CD4 molecules demonstrated increased susceptibility to M. tuberculosis, compared with wild-type mice. MHC class II-/- mice were more susceptible than CD4-/- mice, as measured by survival following M. tuberculosis challenge, but the relative resistance of CD4-/- mice did not appear to be due to increased numbers of CD4-8- (double-negative) T cells. Analysis of in vivo IFN-gamma production in the lungs of infected mice revealed that both mutant mouse strains were only transiently impaired in their ability to produce IFN-gamma following infection. At 2 wk postinfection, IFN-gamma production, assessed by RT-PCR and intracellular cytokine staining, in the mutant mice was reduced by >50% compared with that in wild-type mice. However, by 4 wk postinfection, both mutant and wild-type mice had similar levels of IFN-gamma mRNA and protein production. In CD4 T cell-deficient mice, IFN-gamma production was due to CD8 T cells. Thus, the importance of IFN-gamma production by CD4 T cells appears to be early in infection, lending support to the hypothesis that early events in M. tuberculosis infection are crucial determinants of the course of infection.
Similar articles
-
Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.Eur J Immunol. 1995 Feb;25(2):377-84. doi: 10.1002/eji.1830250211. Eur J Immunol. 1995. PMID: 7875199
-
Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.Vaccine. 2006 Apr 24;24(17):3522-9. doi: 10.1016/j.vaccine.2006.02.005. Epub 2006 Feb 20. Vaccine. 2006. PMID: 16519971
-
XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.J Leukoc Biol. 2007 Nov;82(5):1221-9. doi: 10.1189/jlb.0607426. Epub 2007 Aug 15. J Leukoc Biol. 2007. PMID: 17699612
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
[Analysis of host defense mechanism against mycobacterial infection and its application to therapy with biological response modifiers].Kekkaku. 1994 Nov;69(11):719-23. Kekkaku. 1994. PMID: 7837726 Review. Japanese.
Cited by
-
Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.Clin Exp Immunol. 2017 Feb;187(2):269-283. doi: 10.1111/cei.12871. Epub 2016 Nov 24. Clin Exp Immunol. 2017. PMID: 27665733 Free PMC article.
-
Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients.Immunology. 2013 Sep;140(1):47-60. doi: 10.1111/imm.12108. Immunology. 2013. PMID: 23566249 Free PMC article.
-
Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.PLoS Pathog. 2016 Jun 7;12(6):e1005688. doi: 10.1371/journal.ppat.1005688. eCollection 2016 Jun. PLoS Pathog. 2016. PMID: 27272249 Free PMC article.
-
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.Infect Immun. 2005 Sep;73(9):5809-16. doi: 10.1128/IAI.73.9.5809-5816.2005. Infect Immun. 2005. PMID: 16113299 Free PMC article.
-
Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH.Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8330-5. doi: 10.1073/pnas.102055799. Proc Natl Acad Sci U S A. 2002. PMID: 12060776 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous